This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses may be missing. Find their university profile.
Research
Read how they describe their research on their University of Ottawa profile.
Latest papers
What drives prolonged hospital stays in schizophrenia-spectrum disorders? A Canadian tertiary care review.
PCN reports : psychiatry and clinical neurosciences · 2026 · first author
Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia: Results From an Open-Label, Randomized Crossover Trial.
Journal of clinical psychopharmacology · 2026 · first author
Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia: A Randomized Open-Label Trial.
Journal of clinical psychopharmacology · 2026 · first author
Latest funding
- $10,000
Is there an excess of haematological malignancies in people diagnosed with schizophrenia prescribed clozapine in Ontario: A planning grant to co-design a provincial study
CIHR · 2023 · Nominated PI
- $250,000
From global to local - Global signal topography as novel diagnostic marker in psychiatric disorders
SSHRC · 2020 · Co-investigator
18 publications.
What drives prolonged hospital stays in schizophrenia-spectrum disorders? A Canadian tertiary care review.
Zhand N, Manghi A, Iftikhar F, Zhu Y, Sunderland R, Robertson C
Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia: Results From an Open-Label, Randomized Crossover Trial.
Zhand N, Joober R, Labelle A, Iftikhar F, Robertson C, Harvey PD
Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia: A Randomized Open-Label Trial.
Zhand N, Joober R, Labelle A, Attwood D, Al Quraish F, Iftikhar F, Robertson C, Kozyra E, Carefoot E, Harvey PD
An Exploratory Study of Inflammatory Biomarkers and Extrapyramidal Side Effects in Patients with Schizophrenia.
Zhand N, Carefoot E, Iftikhar F, Zhu Y, Robertson C
Adjunctive methylphenidate extended release in patients with schizophrenia: Protocol of a single-centre fixed dose cross-over open-label trial to improve functional and cognitive outcomes.
Zhand N, Attwood D, Labelle A, Joober R, Robertson C, Harvey PD
Social cognition among clinical subtypes of schizophrenia.
Lee SH, Ekhdoura M, Baek S, Zhand N
Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review.
Arsenault-Mehta K, Hochman-Bérard M, Johnson A, Semenova D, Nguyen B, Willis J, Mouravska N, Joober R, Zhand N
Mortality Rate and Causes of Death in a Canadian Tertiary Schizophrenia Program.
Timm MJ, Robertson CL, Zhand N
Comparison of Extrapyramidal Symptoms Among Outpatients With Schizophrenia on Long-Acting Injectable Antipsychotics.
Zhand N, Labelle A, Ghanem D, Gujral P, Han T, Huneault G, Jain GK, Robertson C
Limitations of access to antipsychotics in Canada: loss of the old and unavailability of the new options.
Zhand N, Desai N, Park A, Dick M
Is there an excess of haematological malignancies in people diagnosed with schizophrenia prescribed clozapine in Ontario: A planning grant to co-design a provincial study
Principal investigators: Zhand, Naista; Attwood, David
Keywords: Clozapine; Haematological Malignancies; Schizophrenia; Side Effects
From global to local - Global signal topography as novel diagnostic marker in psychiatric disorders
Principal investigators: Northoff, Georg
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Psychiatry
- Other
Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.